Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John V Lloyd

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Hematology Reports|August 7, 2003
Recombinant factor VIIa: a universal hemostatic agent?John V Lloyd, J Heinrich Joist
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 21, 2014
Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening testsElizabeth M Duncan, Brian J Dale, John V Lloyd
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven)Charles G Mullighan, Amanda Rischbieth, Elizabeth M Duncan, et al.
British Journal of Haematology|January 16, 2007
In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay resultsSusan E Rodgers, Elizabeth M Duncan, Denise M Barbulescu, et al.
American Journal of Clinical Pathology|August 7, 2002
Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methodsSusan E Rodgers, Nancy V Lerda, Emmanuel J Favaloro, et al.
Pathology|May 1, 2008
Partial and severe factor XI deficiency in South Australia and the usefulness of factor XI mutation analysis for diagnosisElizabeth M Duncan, Graeme J Casey, Matthew P Fenech, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Hematology Reports|August 7, 2003
Recombinant factor VIIa: a universal hemostatic agent?John V Lloyd, J Heinrich Joist
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 21, 2014
Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening testsElizabeth M Duncan, Brian J Dale, John V Lloyd
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven)Charles G Mullighan, Amanda Rischbieth, Elizabeth M Duncan, et al.
British Journal of Haematology|January 16, 2007
In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay resultsSusan E Rodgers, Elizabeth M Duncan, Denise M Barbulescu, et al.
American Journal of Clinical Pathology|August 7, 2002
Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methodsSusan E Rodgers, Nancy V Lerda, Emmanuel J Favaloro, et al.
Pathology|May 1, 2008
Partial and severe factor XI deficiency in South Australia and the usefulness of factor XI mutation analysis for diagnosisElizabeth M Duncan, Graeme J Casey, Matthew P Fenech, et al.
Pageof 1